Dr. Jennifer McVean, MD, stands at the forefront of pediatric diabetes care, blending her personal journey with Type 1 Diabetes and her extensive medical expertise to transform the lives of children and families affected by this condition. Diagnosed at the age of 11, Dr. McVean’s firsthand experience fuels her compassionate approach and innovative contributions to the field.
After earning her medical degree from the University of Minnesota Medical School, Dr. McVean completed her pediatric residency at the University of Colorado and a fellowship in Pediatric Endocrinology and Diabetes at the University of Wisconsin. She is board-certified in both Pediatrics and Pediatric Endocrinology. Her professional journey includes roles at esteemed institutions such as the University of Minnesota, Children’s Minnesota, and Gundersen Health System.
Currently serving as Senior Director of Medical Affairs for Medtronic Diabetes, Dr. McVean focuses on advancing diabetes technology to alleviate the daily burdens faced by patients. Her work has been instrumental in the development of automated insulin delivery systems, including the MiniMed™ 780G system, which has shown significant improvements in glycemic control and quality of life for users. A recent study co-authored by Dr. McVean demonstrated that this system reduces the burden of diabetes management by improving sleep and overnight glycemic control.
Beyond her clinical and research endeavors, Dr. McVean is deeply involved in advocacy and education. She has held leadership positions with organizations such as the Juvenile Diabetes Research Foundation (JDRF) and the American Diabetes Association (ADA). Her commitment extends to mentoring, research, and community outreach, all aimed at enhancing diabetes awareness, prevention, and treatment.
Dr. McVean’s personal mission is to help individuals with diabetes achieve healthier, more independent lives. Her unique perspective as both a patient and a physician enables her to empathize deeply with the challenges faced by those living with diabetes, driving her to develop solutions that make a tangible difference.
Dr. Jennifer McVean has become a respected voice in the Type 1 Diabetes community through her leadership, advocacy, and commitment to advancing diabetes care. Living with Type 1 Diabetes herself, Dr. McVean brings both personal experience and medical expertise to the search for better treatments and, ultimately, a cure.
Her work has helped accelerate awareness of emerging disease-modifying therapies, early detection programs, advanced insulin delivery systems, and next-generation cell-based treatments that are changing the future of Type 1 Diabetes care. Researchers worldwide are now making significant progress toward therapies that may delay, prevent, or one day eliminate the need for lifelong insulin dependence.
As a physician, educator, and advocate, Dr. McVean continues to support groundbreaking research efforts aimed at preserving insulin-producing cells, improving quality of life, and moving the medical community closer to a world without Type 1 Diabetes. While no definitive cure has yet been approved, the pace of innovation has never been greater, and leaders like Dr. McVean are helping drive that progress forward.
For more information about Dr. Jennifer McVean and her work, visit her profile at Hudson Physicians.

